EFFICACIOUS TREATMENT OF NON-SMALL CELL LUNG CANCER WITH NINTEDANIB ESYLATE Application EA-034520-B1 Eurasian Patent Organisation 17 Feb 2020
NINTEDANIB ZUR ANWENDUNG IN DER BEHANDLUNG VON NSCLC Grant EP-2994125-B1 European Patent Office 01 Aug 2018